Skip to main content
. 2021 May 10;62(5):656–664. doi: 10.2967/jnumed.120.250720

FIGURE 7.

FIGURE 7.

Effects of gemcitabine on CT26 tumor expression. (A) Representative tumor PD-L1 immunohistochemistry (magnification, ×12.5 on left and ×400 on right). (B) Immunoblots of tumor tissues (top), and protein band intensities of PD-L1 and PTEN corrected by β-actin and p-AKT corrected by t-AKT (bottom). Bars are means ± SDs (n = 5 per group). *P < 0.05. P < 0.005. P < 0.001.